Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company’s financing ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument ...
Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what's possible with PCR for rare event detection. By delivering 10 times more sensitivity ...
Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; ...
Countable Labs, announced the closing of an oversubscribed $26 million financing round to enable the development of fit-for-purpose solutions leveraging 10-color capabilities to support cell and gene ...
Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction. The system extends the company’s Countable PCR technology, which ...
DNA and RNA are central to laboratory and clinical research, where quantifying their abundance is key to applications such as gene expression analysis, cell and gene therapy development, and ...
Alex Zevin, PhD, began serving as the director of the Genomics Shared Resource at Fred Hutch in December 2022. Before that, he was a research scientist at ArcherDX where he developed NGS in vitro ...
Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results